Search for: "Patent Docs" Results 741 - 760 of 1,638
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include… [read post]
20 May 2010, 3:12 am by Lawrence B. Ebert
In a post titled With Overhaul of Patent Law Stalled, House To Consider Narrower Bill, CQ Politics discusses a limited-scope patent reform bill of Congressman Conyers, the House Judiciary Chairman.The problem is that a grant of fee setting authority to the USPTO without ending fee diversion from the USPTO merely means that patent applicants will be paying more for less.The problem with ending fee diversion has been documented by Marla Grossman, so that the current… [read post]
24 Nov 2010, 9:55 pm by Patent Docs
With the launch of the USPTO Twitter account, Patent Docs would like to take the opportunity to remind its readers that Patent... [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin… [read post]
8 Jun 2015, 10:07 am by Dennis Crouch
  Only a small percentage of all patents are used in litigation or licensing; these patents are considered the top tier of all patents. [read post]
31 Oct 2007, 4:10 am
  Click here for Patent Docs' excellent coverage of the SmithKline/GSK suit.The two suits were consolidated and a preliminary injunction hearing has been set for today -- click here and here to download the briefs at Patently-O. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Roundup Ready Soybean: Infringement of US patent: Monsanto Co. et al. v. [read post]
30 Jun 2020, 4:09 am by Barry Barnett
Contempt action for violation of bankruptcy discharge order belonged in court despite arbitration clause. https://ca2.uscourts.gov/decisions/isysquery/c8b45000-e918-438d-9027-23e88f01dfe4/1/doc/19-648_opn.pdf#xml=https://www.ca2.uscourts.gov/decisions/isysquery/c8b45000-e918-438d-9027-23e88f01dfe4/1/hilite/ DACA survives. https://supremecourt.gov/opinions/19pdf/18-587_5ifl.pdf Lawyer who won judgment on Argentine bonds had lien on proceeds of settlement he didn’t participate in and… [read post]
11 Nov 2008, 7:46 am
Ebert.Last Updated: November 10, 2008 - Rank Today: 9http://ipbiz.blogspot.comPatent Troll Tracker [feed]Tracks patent litigation.Last Updated: March 25, 2008 - Rank Today: 18http://trolltracker.blogspot.com/AlsoPatent Docs [feed]Covers biotech and pharma patent law and news. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca… [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome… [read post]
25 Aug 2010, 12:37 am by Kelly
Patent and Trademark Office (Patent Docs) (Patent Docs) US: PTO files amicus brief in Therasense case (Patent Docs) (Patent Docs) US: AMP v. [read post]
18 Aug 2010, 12:19 am by Kelly
Cir. 2010) (Patent Docs) (Patent Docs) US: CAFC: Inherent anticipation and inherent obviousness? [read post]
30 Apr 2012, 7:40 am by admin
The “Doc” – Lawrence A Husick, Esq. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango)   General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian… [read post]
3 Feb 2009, 8:33 am
"Also, it appears that Gregg was not always a fan of the DOC. [read post]